Mallinckrodt to proceed with appeal in ongoing acthar gel medicaid drug rebate dispute with cms

Mallinckrodt to proceed with appeal despite appellate court decision denying temporary injunction in ongoing acthar gel medicaid drug rebate dispute with the centers for medicare and medicaid services (cms).mallinckrodt plc - company remains committed to opioid settlement in principle.mallinckrodt plc - company continues to explore all options to address its long-term liabilities and risks.mallinckrodt plc - as a result of appeals court ruling, co will change base date amp for acthar gel.mallinckrodt - effect of change is immediate recognition of retroactive non-recurring charges (estimated at about $650 million through mid-june).
MNK Ratings Summary
MNK Quant Ranking